CRVL in three months: buy, wait or sell?
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
- Buy / Wait / Sell rating
- 3-month target price
- Bear · Base · Bull
- vs. the market
What happened with CRVL today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
CorVel helps U.S. insurers, employers that fund their own insurance claims, claims administrators and government entities handle claims and the associated medical care. Most revenue comes from patient management: administering claims, coordinating injured employees’ treatment and rehabilitation, and helping them return to work. Customers pay for a complete claims-management program or selected services, chiefly for workers’ compensation but also for other insurance claims.
The other substantial revenue source is network solutions. CorVel reviews medical bills to identify potential savings and arranges care through provider networks, including its CareIQ directed-care network. These services help customers manage what they pay for treatment in workers’ compensation, auto and group-health claims. Proprietary claims and bill-review software supports the work.
The business depends on customers continuing to outsource claims work and on the volume of claims and medical care requiring its services, rather than on one dominant customer. Medical-review operations and provider networks must meet applicable state licensing and operating requirements. In reviewing whether treatment is appropriate, CorVel makes recommendations; it does not grant or deny benefit-payment claims.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
CorVel Corp’s results hinge on employers outsourcing workers’ compensation claims and on earning more per medical bill reviewed—not on insurance brokerage commissions or underwriting profits.
Crawford & Company’s Broadspire business competes with CorVel Corp for self-insured employers that pay outside providers to administer workers’ compensation claims, manage injured workers’ care and contain medical costs.
Arthur J. Gallagher & Co. and CorVel Corp both earn fees from self-insured organizations for administering and settling property-and-casualty claims. Watch Gallagher’s risk-management revenue for this overlap, rather than its insurance-placement business: risk management accounted for about 13% of its 2025 revenue, versus about 87% from brokerage.
ExlService Holdings, Inc. competes with CorVel Corp where insurers and healthcare payers hire outside firms to run claims operations and check medical payments for errors or overcharges; EXL’s services overlap with CorVel’s claims administration and medical bill review.
ExlService Holdings, Inc. earningsEXLS
ExlService Holdings, Inc.’s report will show whether insurers and healthcare payers are buying more outsourced claims operations and medical bill review, services that overlap with CorVel’s.
Look for signs of demand and growth in EXL’s claims-operations and medical bill-review work. Strength would suggest payers are outsourcing more claims handling and payment checks, supporting demand for CorVel’s overlapping services. Weakness would point to softer outsourcing demand or tougher competition for contracts, putting more pressure on CorVel’s related business.
Arthur J. Gallagher & Co. earningsAJG
Arthur J. Gallagher & Co.’s report will show whether its risk-management business is gaining or losing claims-administration work from self-insured organizations, a market it shares with CorVel.
Focus on Gallagher’s risk-management revenue, not its overall revenue, which is mostly insurance brokerage. Growth in risk management would suggest self-insured organizations are placing more claims work with outside providers, supporting the market CorVel shares; a decline would point to weaker demand for outsourced claims administration.
Crawford & Company earningsCRD-A
Crawford & Co.’s report will show whether its Broadspire business is gaining workers’ compensation claims and care-management work from self-insured employers, where it competes directly with CorVel.
Look for growth or demand signals in Broadspire’s related business. Strength would show self-insured employers are still buying outsourced claims administration, injured-worker care and medical-cost control, but also that a direct competitor is winning work in CorVel’s market. Weakness would suggest softer demand or less competitive pressure.
Corvel Corp earningsThis company
CorVel’s report will show whether customers are expanding enhanced bill review while its larger patient-management business keeps growing.
Compare network-solutions revenue with patient-management revenue. If the former keeps growing and the latter also advances steadily, customers are adding bill-review work without weakening CorVel’s larger service base. If network-solutions growth slows or patient-management revenue falls, the newer growth engine is fading or the core business is under pressure.